Biosynthesis of fredericamycin A, a new antitumor antibiotic.
Fredericamycin A (FM A), produced by a strain of Streptomyces griseus, represents a new structural class of antitumor antibiotics containing a spiro ring system. Studies on the producer organism showed that glucose in the fermentation medium is not utilized until late in the growth stage, just prior to synthesis of FM A. [14C]Glucose tracer experiments demonstrated that glucose is incorporated into FM A by catabolism to acetate. Biosynthetic enrichment of FM A with single- and double-labeled [13C]acetate showed that the entire carbon skeleton of the spiro ring system is derived from acetate. L-Methionine was shown to provide the only nonskeletal carbon in FM A, the methoxy carbon at position C-6. The direction of the polyketide chain and the position of the carbon lost during biosynthesis were established by using stable isotope experiments. A general model for FM A biosynthesis is proposed, and a possible scheme for the formation of the spiro carbon center is presented.
D000085:Acetates / Q000378:metabolism; D019342:Acetic Acid; D000903:Antibiotics, Antineoplastic / Q000096:biosynthesis*; D005947:Glucose / Q000378:metabolism; D008314:Malonates / Q000378:metabolism; D013305:Streptomyces griseus / Q000378:metabolism*
D000085:Acetates; D000903:Antibiotics, Antineoplastic; D008314:Malonates; C030290:malonic acid; D005947:Glucose; D019342:Acetic Acid